Patient Cases Shedding Light on Vitiligo Management

Panelists discuss how vitiligo treatment delays, psychosocial effects, and emerging therapies impact standard of care for patients through case-based analysis.

Panelists discuss how to improve treatment adherence, incorporate adjunctive therapies, and simplify complex regimens for patients with vitiligo through case-based analysis.

Panelists discuss how phototherapy, combination treatments, and patient-centered strategies can be utilized to enhance quality of life for individuals with vitiligo.

Panelists discuss how to address treatment challenges and manage site-specific concerns in vitiligo patients, drawing on expert insights and clinical experience.

Panelists discuss how novel treatment mechanisms, efficacy assessments, and improved patient engagement strategies are shaping the evolving landscape of vitiligo management.

Panelists discuss how their clinical experiences with topical ruxolitinib are shaping new treatment paradigms for vitiligo, while also addressing challenges related to medication access.

Panelists discuss how treatment cycling strategies and optimal use of ruxolitinib can enhance the management of vitiligo, providing key takeaways for clinical practice.

In a Dermatology Times Case-Based Peer Perspective event, Terry Faleye, MPAS, PA-C, reviewed 2 cases of patients with vitiligo to discuss innovative treatments and emotional challenges with disease management.